InsiderDirector

Phillip Frost MD ET AL Insider Trading Activity

Every SEC Form 4 transaction reported by Phillip Frost MD ET AL, sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Is Phillip Frost MD ET AL buying or selling?

Phillip Frost MD ET AL reported 256 open-market buys ($86.6M) and 7 sells ($225.1M) across 263 Form 4 filings at 8 companies — a net selling position of $138.5M.

Source: SEC EDGAR Form 4

Key Statistics (as of Feb 25, 2026)

Total Form 4 filings
263
SEC EDGAR
Companies
8
Buys (256)
$86.6M
Sells (7)
$225.1M

Insider sentiment

Net selling

Net insider flow of $138.5M in net selling, filed between May 1, 2018 – Feb 25, 2026.

Companies Phillip Frost MD ET AL files for

#CompanyForm 4 filings
1OPKOpko Health, Inc.243
2COCPCocrystal Pharma, Inc.8
3VGRVECTOR GROUP LTD5
4BCDABioCardia, Inc.3
5LTSLADENBURG THALMANN FINANCIAL SERVICES INC.1
6NIMUNON INVASIVE MONITORING SYSTEMS INC /FL/1
7NNUPNOCOPI TECHNOLOGIES INC/MD/1
8ROXCastle Brands Inc1

Recent Phillip Frost MD ET AL transactions

DateTickerRoleTypeSharesValue
Feb 25, 2026COCPDirector, 10% OwnerPurchase20.0K$20.0K
Feb 9, 2026COCPDirector, 10% OwnerPurchase50.0K$47.3K
Jan 2, 2026COCPDirector, 10% OwnerPurchase50.0K$47.3K
Dec 31, 2025COCPDirector, 10% OwnerPurchase20.0K$19.3K
Dec 29, 2025COCPDirector, 10% OwnerPurchase65.0K$63.2K
Nov 28, 2025COCPDirector, 10% OwnerPurchase4.0K$4.0K
Nov 26, 2025COCPDirector, 10% OwnerPurchase20.0K$18.8K
Nov 21, 2025OPKCEO & ChairmanPurchase580.0K$768.8K
Nov 20, 2025OPKCEO & ChairmanPurchase580.0K$771.3K
Nov 19, 2025OPKCEO & ChairmanPurchase580.0K$759.1K
Nov 18, 2025OPKCEO & ChairmanPurchase533.3K$678.9K
Oct 31, 2025OPKCEO & ChairmanPurchase150.0K$213.4K
Aug 8, 2025OPKCEO & ChairmanPurchase675.0K$891.0K
Jun 11, 2025NNUP10% OwnerPurchase195.9K$215.4K
Apr 10, 2025OPKCEO & ChairmanPurchase125.0K$169.7K
Apr 8, 2025OPKCEO & ChairmanPurchase125.0K$184.7K
Apr 1, 2025OPKCEO & ChairmanPurchase100.0K$164.8K
Mar 28, 2025OPKCEO & ChairmanPurchase150.0K$254.4K
Mar 17, 2025OPKCEO & ChairmanPurchase200.0K$347.8K
Mar 1, 2025OPKCEO & ChairmanPurchase67.4K$115.3K
Jan 28, 2025OPKCEO & ChairmanPurchase47.5K$70.1K
Jan 17, 2025OPKCEO & ChairmanPurchase150.0K$220.4K
Jan 15, 2025OPKCEO & ChairmanPurchase500.0K$740.9K
Dec 13, 2024OPKCEO & ChairmanPurchase125.0K$199.4K
Dec 11, 2024OPKCEO & ChairmanPurchase500.0K$781.0K

Showing the 25 most recent filings of 263. Screen every filing.

Phillip Frost MD ET AL insider trading FAQ

Is Phillip Frost MD ET AL buying or selling?

Across 263 SEC Form 4 filings, Phillip Frost MD ET AL reported 256 open-market purchases totaling $86.6M and 7 sales totaling $225.1M — a net selling position of $138.5M.

Which companies does Phillip Frost MD ET AL file Form 4s for?

Phillip Frost MD ET AL has reported insider transactions at 8 companies, most often Opko Health, Inc. (OPK), Cocrystal Pharma, Inc. (COCP), VECTOR GROUP LTD (VGR), BioCardia, Inc. (BCDA), LADENBURG THALMANN FINANCIAL SERVICES INC. (LTS).

How far back does Phillip Frost MD ET AL's filing history go?

Trabud holds Phillip Frost MD ET AL's SEC Form 4 filings from May 1, 2018 – Feb 25, 2026, sourced directly from SEC EDGAR.

Where does Trabud get Phillip Frost MD ET AL's insider trading data?

Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.

Related Content

Track Phillip Frost MD ET AL and every other insider

Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.

Open the screener